Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose in Parkinson's Disease
NCT05355064Phase 4Unknown
- Sponsor
- Neuromed Pharmaceuticals
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of trehalose in Parkinson's disease (PD), sponsored by Neuromed Pharmaceuticals. Status: unknown.
02
Drugs
trehalose
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05355064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05355064.